Clinical.ly is excited to exhibit in person at the ACRP Expo in Orlando, Florida April 22nd – April 25th. The ACRP Expo is one of the premier education and networking events for Clinical Research Professionals globally. The Clinical.ly team is grateful for the opportunity to learn from those in attendance and discuss the myriad of ways the Clinical.ly Research Suite may help clinical research organizations achieve their goals.
Please feel free to stop by Booth 221 where Clinical.ly CEO Henry Kravchenko, and EVP, Business Operations Angel Pettitt will be showcasing Clinical.ly’s flagship eRegulatory solution while also introducing the new eSource component.
Angel Pettitt had this to say “As a company that prides itself on listening and responding to the challenges our customers face, we welcome the opportunity to engage with clinical trial professionals at a forum like the ACRP Expo. The opportunity to hear first hand what sites need from their technology partners is invaluable to our continued growth in the industry.”
The Association of Clinical Research Professionals (ACRP) supports clinical research professionals through membership, training and development, and certification. Founded in 1976, ACRP is a Washington, DC-based non-profit organization with more than 13,000 members who work in clinical research in more than 70 countries.
Clinical.ly provides differentiated technological solutions to the clinical research industry, which helps research facilities focus on conducting studies as efficiently as possible. The company is dedicated to developing technology that reduces or eliminates tedious manual labor so that you can focus on both patient care and study growth. While your top priority is always the patient, the success of your business hinges on satisfying all your stakeholders.
Clinical research sites operate in a highly regulated, fast-moving, and constantly evolving environment, with stakeholders ranging from international multibillion-dollar corporations to individual patients involved in clinical trials, to federal and industry regulators. The industry tests cutting-edge drugs and medical devices but is often saddled with outdated and unintuitive software that complicates investigators, coordinators, and physicians’ jobs.